Hans Bishop

Hans Edgar Bishop was the founder of Juno Therapeutics, Inc., founded in 2013, where the titles held included President, Chief Executive Officer & Director from 2013 to 2018.
Mr. Bishop is the founder of Sana Biotechnology, Inc., founded in 2018, holding the title of Chairman since 2018.
Mr. Bishop is the founder of Altos Labs, Inc., founded in 2021, holding the titles of Co-Chairman & President since 2021.
Current jobs include Director at JW Biotechnology (Shanghai) Co. Ltd., Director at JW Therapeutics (Shanghai) Co., Ltd., and Director at Ophirex, Inc. since 2020.
Former jobs include Chief Executive Officer & Director at GRAIL, Inc. from 2019 to 2021; Executive Chairman at Iovance Biotherapeutics, Inc. in 2012; Director at Celgene Corp.
from 2018 to 2019; Independent Director at Avanir Pharmaceuticals, Inc. from 2013 to 2015; President & Director at X-Body, Inc.; Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd. from 2017 to 2021; Independent Director at Agilent Technologies, Inc. from 2017 to 2024; Independent Director at Lyell Immunopharma, Inc. from 2018 to 2024; Senior Vice President-Global Commercial Operations at Chiron Corp.
from 2004 to 2006; Executive-in-Residence at Warburg Pincus LLC; Principal at Glaxo Wellcome Plc; Chief Operating Officer & Executive Vice President at Dendreon Corp.
from 2010 to 2011; Chief Operating Officer at PhotoThera, Inc. in 2012; President-Specialty Medicine Business at Bayer HealthCare Pharmaceuticals, Inc. from 2006 to 2010; Vice President & General Manager at European Biopharmaceutical Enterprises; Principal at GlaxoSmithKline LLC; Chief Operating Officer & Executive Vice President at Dendreon Pharmaceuticals, Inc. Education includes an undergraduate degree from Brunel University conferred in 1987.